Press Releases

Press Releases

Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating

Samsung%20Biologics%20receives%20EcoVaids%20Platinum,%20the%20highest%20sustainability%20rating_Image.png

- Platinum Rating recognizes Samsung Biologics’ strategic sustainability performance

- Samsung Biologics ranked in the top one percent of more than 100,000 companies

 

Incheon, S. Korea, January 22, 2024 – Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced that the company was awarded the EcoVadis’ Platinum Sustainability Rating, the highest recognition given, for the company’s sustainability management.
 

The Platinum Rating places Samsung Biologics in the top one percent of the over 100,000 companies assessed by EcoVadis, a global evaluation platform that assesses the corporate social responsibility performances of companies in four main areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. Samsung Biologics received the Gold Sustainability Rating in 2022.
 

"The Platinum Rating underscores our sustainability leadership and reflects our unwavering commitment to decarbonization, ethics, and responsible business practices," said John Rim, CEO and President of Samsung Biologics. "We understand that sustainability is increasingly important to all our customers and this latest accreditation reaffirms our mission in creating a healthier future for society through better services and business practices."
 

Samsung Biologics has been publishing annual Environmental, Social, and Governance reports, outlining its green strategies towards decarbonization and efforts to engage suppliers to minimize potential social and ethical risks. The company is committed to achieving zero greenhouse gas emissions and 100% renewable energy across its sites and supply chains by 2050.
 

Samsung Biologics is also a member of the Sustainable Markets Initiative (SMI) and was the first CDMO to receive the SMI’s Terra Carta Seal, in recognition of the company’s efforts to drive innovation and demonstrate commitment to the creation of sustainable markets. Samsung Biologics has also joined global initiatives, including the Sustainable Aviation Buyers Alliance and the United Nations Global Compact.
 

For more details and updates on our sustainability efforts, please visit here

Samsung%20Biologics%20receives%20EcoVaids%20Platinum,%20the%20highest%20sustainability%20rating_Image.png

- Platinum Rating recognizes Samsung Biologics’ strategic sustainability performance

- Samsung Biologics ranked in the top one percent of more than 100,000 companies

 

Incheon, S. Korea, January 22, 2024 – Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced that the company was awarded the EcoVadis’ Platinum Sustainability Rating, the highest recognition given, for the company’s sustainability management.
 

The Platinum Rating places Samsung Biologics in the top one percent of the over 100,000 companies assessed by EcoVadis, a global evaluation platform that assesses the corporate social responsibility performances of companies in four main areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. Samsung Biologics received the Gold Sustainability Rating in 2022.
 

"The Platinum Rating underscores our sustainability leadership and reflects our unwavering commitment to decarbonization, ethics, and responsible business practices," said John Rim, CEO and President of Samsung Biologics. "We understand that sustainability is increasingly important to all our customers and this latest accreditation reaffirms our mission in creating a healthier future for society through better services and business practices."
 

Samsung Biologics has been publishing annual Environmental, Social, and Governance reports, outlining its green strategies towards decarbonization and efforts to engage suppliers to minimize potential social and ethical risks. The company is committed to achieving zero greenhouse gas emissions and 100% renewable energy across its sites and supply chains by 2050.
 

Samsung Biologics is also a member of the Sustainable Markets Initiative (SMI) and was the first CDMO to receive the SMI’s Terra Carta Seal, in recognition of the company’s efforts to drive innovation and demonstrate commitment to the creation of sustainable markets. Samsung Biologics has also joined global initiatives, including the Sustainable Aviation Buyers Alliance and the United Nations Global Compact.
 

For more details and updates on our sustainability efforts, please visit here

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION